DDIT3 and diffuse large B-cell lymphoma: Moreover, high MELK expression levels were associated with a significant worse survival in DLBCL patients (93 ABC-, 108 GCB-, and 32 unclassified DLBCL patients) receiving R-CHOP treatment (Fig. 1b).